IL22583A - Pilocarpine benzoate - Google Patents
Pilocarpine benzoateInfo
- Publication number
- IL22583A IL22583A IL2258364A IL2258364A IL22583A IL 22583 A IL22583 A IL 22583A IL 2258364 A IL2258364 A IL 2258364A IL 2258364 A IL2258364 A IL 2258364A IL 22583 A IL22583 A IL 22583A
- Authority
- IL
- Israel
- Prior art keywords
- pilocarpine
- benzoate
- preparation
- reacted
- organic solvent
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Description
This invention consists in a hitherto unknown
salt of pilocarpine, the alkaloid obtainable from, for
example, the leaves of Pilocarpus Jaborandi or Pilocarpus microphallus.
of pilocarpine with conventional acids,
the hydrochloride and nitrate, are used for therapeutical purposes, especially for the treatment of glaucoma by external application. In this use they have the drawback that their pH in solution is relatively low and the eye liquid becomes undesirably acidic*
The invention provides a new pilocarpine salt
which does not have this drawback, namely: pilocarpine benzoate.
This new compound can be prepared by the direct reaction of pilocarpine with benzoic acid, or by the double decompositio of another pilocarpine salt with a benaoate.
The reaction is asa rule carried out in an aqueous or organic-solvent medium.
The new pilocarpine benaoate can be prepared in a pure crystalline form. The purest samples so ar prepared have the melting pint 93 - 95°C and a specific rotation (in a
as een oun t at the desired therapeutic
ophthalmologlcal properties of pilocarpine benzoate are at least equal to those of the conventional pilocarpine salts, apart from their considerable advantage of not appreciably lowering the pH of the eye liquid.
The invention is illustrated by the following Examples to which it ia not limited*
Example 1
grams of pilocarpine base are admixed to the solution of 5.9 grams of benzoic acid in 25 ml of methanol, then the volume of the reaction is reduced to one thir^d by evaporation of the methanol. There forms a white crystalline mass of pilocarpine benzoate which is recrystallized from amyl alcohol. After recrystallization the pure product has the melting point and optical rotation stated above*
Example 2
grams of pilocarpine base are taken up in 10 ml of amyl alcohol and admixed with a hot solution of 5.9 grams of benzoic acid i 40 ml of amyl alcohol· The mixture is left to cool and the crystalline mass of pilocarpine benzoate thereby formed is separated from the solvent by filtration. Hecrystabilization from amyl alcohol yields the same pure product as in Example 1.
Example 3
A concentrated aqueous solution of 10 grams of pilocarpine hydrochloride is admixed with the solution of 6.3 grams of sodium benzoate i 10 ml of water. The aqueous reaction solutio is extracted with chloroform whereby pilocarpine benzoate is transferred into the solvent phase while sodium chloride remains in the aqueous phase. The solvent phase is separated and dried over sodium sulfate, then the chloroform is completely evaporated. The dry
residue of pilocarpine benzoate is recryatallized from butanol and is then as pure as the product of Examples 1 and 2·
Claims (1)
- HAVIHCa1 HOW particularly described and ascertained the nature of our said invention and in what manner the same is to be performed, we declare that what we claim is:-1, Pilocarpine benzoate. 2· Pilocarpine benzoate, being a crystalline product of m.p, 93 - 95°C and [dj ^« + 65° (in 25¾«-by-weight aqueous solution), 3. A process for the preparation of pilocarpine benzoate, wherein pilocarpine base is reacted with benzoic acid in an organic solvent medium. 4· A process for the preparation of pilocarpine benzoate, wherein another pilocarpine salt, e.g. the hydrochloride, a reacted with a benzoate, e.g. the sodium salt, in an aqueous medium, the reaction mixture is extracted with an organic solvent, and pilocarpine benzoate is recovered from the solvent extract. 5· Process for the preparation of pilocarpine benzoate substantially as described with reference to the Bxamples. 6. Pilocarpine benzoate, when prepared by the process according to Claim 3, 4 or 5· 7· Therapeutic, especially opthalmological, preparations containing pilocarpine benzoate. Dated this 7th day of December, 1964
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL2258364A IL22583A (en) | 1964-12-08 | 1964-12-08 | Pilocarpine benzoate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL2258364A IL22583A (en) | 1964-12-08 | 1964-12-08 | Pilocarpine benzoate |
Publications (1)
Publication Number | Publication Date |
---|---|
IL22583A true IL22583A (en) | 1968-03-28 |
Family
ID=11043443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL2258364A IL22583A (en) | 1964-12-08 | 1964-12-08 | Pilocarpine benzoate |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL22583A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023143575A1 (en) * | 2022-01-29 | 2023-08-03 | 南京济群医药科技股份有限公司 | M-choline receptor agonist compound, preparation method therefor and use thereof |
-
1964
- 1964-12-08 IL IL2258364A patent/IL22583A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023143575A1 (en) * | 2022-01-29 | 2023-08-03 | 南京济群医药科技股份有限公司 | M-choline receptor agonist compound, preparation method therefor and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT366050B (en) | METHOD FOR PRODUCING A HYDRATED CRYSTALLINE FORM OF THE SODIUM SALT OF AN OXIDE DERIVATIVE OF THE 7-AMINOTHIAZOLYL ACETAMIDOCEPHALOSPO RANIC ACID | |
US3959247A (en) | TRH tartrate crystals | |
US3707534A (en) | Method for production of lactulose concentrate | |
IL22583A (en) | Pilocarpine benzoate | |
PT101006B (en) | PREPARATION PROCEDURE OF (S) (+) - 4,4- (1-METHYL-1,2-ETHANODYL) -BIS- (2,6-PIPERAZINADIONA) AND USE AS A MEDICATION. | |
US3532684A (en) | Molecular compounds of inosine and tryptophan | |
US2727041A (en) | Isonicotinyl hydrazone of m-formyl-benzene sulfonic acid | |
JPS6358839B2 (en) | ||
Parke et al. | The preparation and properties of sodium d-pantothenate | |
US1954389A (en) | Process of manufacturing optically active mono-hydroxyphenyl methylamino-ethanols-1 | |
US2950287A (en) | Preparation of water soluble epinochrome derivatives | |
US3790587A (en) | Antimycotic benzisothiazoline derivatives | |
US3290325A (en) | Soluble alkanol ammonium thiazolidine carboxylates | |
Serajuddin | Comparative thermal properties of the monohydrates of sodium theophylline and theophylline | |
US4124636A (en) | Method of preparing monopotassium L-malate and its monohydrate | |
US2857376A (en) | Water-insoluble crystalline streptomycin and dihydrostreptomycin salts and method ofpurifying streptomycin and dihydrostreptomycin by means thereof | |
US2867661A (en) | Non-hygroscopic antibiotic salt | |
US3651048A (en) | Purification process | |
US2208641A (en) | Soluble sulphanilic acid amide derivatives | |
US2868804A (en) | Betaine ascorbate | |
AT227699B (en) | Process for the preparation of new quaternary 1- (2-lower. Alkyl-4-amino-5-pyrimidyl-methyl) -low. alkyl pyridinium salts | |
US3714166A (en) | Cocarboxylase arginate and process for the production thereof | |
DE1693190C3 (en) | Alkanes and hydroxyalkanes disubstituted by alkylsulfonyloxyethylamino groups, processes for their preparation and pharmaceutical preparations containing these compounds | |
US2668852A (en) | Neutral calcium 4-aminosalicylate hemihydrate and preparation of the same | |
US2476925A (en) | Preparation of therapeutic substances |